The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
118379962 11837996 2 F 20151123 20160624 20151215 20160706 EXP PL-PFIZER INC-2015443213 PFIZER 65.00 YR M Y 62.00000 KG 20160706 MD PL PL

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
118379962 11837996 1 SS PF-06439535 INVESTIGATIONAL PRODUCT 1 Intravenous (not otherwise specified) 930 MG, EVERY 3 WEEKS 930 MG 0 930 MG SOLUTION FOR INFUSION Q3W
118379962 11837996 2 PS CARBOPLATIN. CARBOPLATIN 1 Intravenous (not otherwise specified) 881.13 MG, EVERY 3 WEEKS 881 MG 76517 881.13 MG Q3W
118379962 11837996 3 SS PACLITAXEL. PACLITAXEL 1 Intravenous (not otherwise specified) 348 MG, EVERY 3 WEEKS 348 MG 76131 348 MG Q3W
118379962 11837996 4 C DEXAMETHASONE. DEXAMETHASONE 1 Intravenous (not otherwise specified) 20 MG, 2X/DAY 0 20 MG BID
118379962 11837996 5 C CLEMASTIN CLEMASTINE 1 Intravenous (not otherwise specified) 2 MG, 1X/DAY, ONCE 0 2 MG QD
118379962 11837996 6 C RANIGAST 2 Intravenous (not otherwise specified) 50 MG, 1X/DAY, ONCE 0 50 MG QD
118379962 11837996 7 C ZOFRAN ONDANSETRON HYDROCHLORIDE 1 Intravenous (not otherwise specified) 16 MG, 1X/DAY, ONCE 0 16 MG QD
118379962 11837996 8 C NATRIUM CHLORATUM 0.9% 2 Intravenous (not otherwise specified) 500 ML, 1X/DAY 0 500 ML QD
118379962 11837996 9 C KETONAL KETOPROFEN 1 Oral 0.05 G, 1X/DAY 0 .05 G QD
118379962 11837996 10 C BUSCOLIZYN 2 Intravenous (not otherwise specified) 20 MG, 1X/DAY 20 MG 0 20 MG QD
118379962 11837996 11 C IPP /00661201/ 2 Oral 20 MG, 1X/DAY 20 MG 0 20 MG QD

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
118379962 11837996 1 Non-small cell lung cancer
118379962 11837996 2 Non-small cell lung cancer
118379962 11837996 3 Non-small cell lung cancer
118379962 11837996 4 Premedication
118379962 11837996 5 Premedication
118379962 11837996 6 Premedication
118379962 11837996 7 Antiemetic supportive care
118379962 11837996 11 Premedication

Outcome of event

Event ID CASEID OUTC COD
118379962 11837996 DE

Reactions reported

Event ID CASEID DRUG REC ACT PT
118379962 11837996 Death

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
118379962 11837996 1 20151119 20151119 0
118379962 11837996 2 20151119 20151119 0
118379962 11837996 3 20151119 20151119 0
118379962 11837996 4 20151119 20151119 0
118379962 11837996 5 20151119 20151119 0
118379962 11837996 6 20151119 20151119 0
118379962 11837996 7 20151119 20151119 0
118379962 11837996 8 20151119 20151119 0
118379962 11837996 9 20151119 20151119 0
118379962 11837996 10 20151119 20151119 0
118379962 11837996 11 20151119 20151119 0